Cargando…
Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up
Serum and urine samples were collected from 33 NCC patients before the albendazole treatment, 3–6 and 12 months PT. At 3 months PT, 24 (72.7%) patients had no detectable CT/MRI lesions and 9 (27.2%) patients had persistent lesions. Antibody response to crude soluble extract (CSE), excretory secretor...
Autores principales: | Atluri, Venkata Subba Rao, Gogulamudi, Venkateswara Reddy, Singhi, Pratibha, Khandelwal, Niranjan, Parasa, Lakshmana Swamy, Malla, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158118/ https://www.ncbi.nlm.nih.gov/pubmed/25215297 http://dx.doi.org/10.1155/2014/904046 |
Ejemplares similares
-
Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series
por: Cárdenas, Graciela, et al.
Publicado: (2010) -
Downregulation of host tryptophan–aspartate containing coat (TACO) gene restricts the entry and survival of Leishmania donovani in human macrophage model
por: Gogulamudi, Venkateswara Reddy, et al.
Publicado: (2015) -
Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis
por: Kumar, Animesh, et al.
Publicado: (2017) -
Pediatric neurocysticercosis: current challenges and future prospects
por: Singhi, Pratibha, et al.
Publicado: (2016) -
Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba
por: Shing, Brian, et al.
Publicado: (2022)